The degradation pathway for the HBV envelope proteins involves proteolysis prior to degradation via the cytosolic proteasome

Virology

Volumn 369, Issue 1, 2007, Pages 69-77

  Liu, Yuanjie ^a   Zhou, Tianlun ^b   Simsek, Ender ^a   Block, Timothy ^a   Mehta, Anand ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b BARUCH S BLUMBERG INSTITUTE   (United States)

Author keywords

Antigen presentation; Degradation; Glycosylation; Hepatitis B virus; Immune escape

Indexed keywords

ENDOGLYCOSIDASE H; ENVELOPE PROTEIN; GLYCAN; GLYCOSIDASE; N ACETYL BETA GLUCOSAMINIDASE; POLYPEPTIDE; PROTEASOME; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOSOL; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; CYTOSOL; ENDOPEPTIDASES; HEPATOCYTES; HUMANS; IMMUNOBLOTTING; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; PROTEASOME ENDOPEPTIDASE COMPLEX; VIRAL ENVELOPE PROTEINS;

HEPATITIS B VIRUS;

EID: 35649028763     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.06.048     Document Type: Article

References (29)

1. Bacik I., Snyder H.L., Anton L.C., Russ G., Chen W., Bennink J.R., Urge L., Otvos L., Dudkowska B., Eisenlohr L., and Yewdell J.W. Introduction of a glycosylation site into a secreted protein provides evidence for an alternative antigen processing pathway: transport of precursors of major histocompatibility complex class I-restricted peptides from the endoplasmic reticulum to the cytosol. J. Exp. Med. 186 4 (1997) 479-487
2. de Silva A.M., Balch W.E., and Helenius A. Quality control in the endoplasmic reticulum: folding and misfolding of vesicular stomatitis virus G protein in cells and in vitro. J. Cell Biol. 111 3 (1990) 857-866
3. Dwek R.A., Edge C.J., Harvey D.J., Wormald M.R., and Parekh R.B. Analysis of glycoprotein-associated oligosaccharides. Annu. Rev. Biochem. 62 4 (1993) 65-100
4. Dwek R.A., Butters T.D., Platt F.M., and Zitzmann N. Targeting glycosylation as a therapeutic approach. Nat. Rev., Drug Discov. 1 1 (2002) 65-75
5. Gerlich W.H., Heermann K.H., and Lu X. Functions of hepatitis B surface proteins. Arch. Virol., Suppl. 4 (1992) 129-132
6. Helenius A., and Aebi M. Roles of N-linked glycans in the endoplasmic reticulum. Annu. Rev. Biochem. 73 (2004) 1019-1049
7. Hirsch C., Blom D., and Ploegh H.L. A role for N-glycanase in the cytosolic turnover of glycoproteins. EMBO J. 22 5 (2003) 1036-1046
8. Hsieh Y.H., Su I.J., Wang H.C., Chang W.W., Lei H.Y., Lai M.D., Chang W.T., and Huang W. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25 10 (2004) 2023-2032
9. Huang Z.M., Tan T., Yoshida H., Mori K., Ma Y., and Yen T.S. Activation of hepatitis B virus S promoter by a cell type-restricted IRE1-dependent pathway induced by endoplasmic reticulum stress. Mol. Cell. Biol. 25 17 (2005) 7522-7533
10. Hung J.H., Su I.J., Lei H.Y., Wang H.C., Lin W.C., Chang W.T., Huang W., Chang W.C., Chang Y.S., Chen C.C., and Lai M.D. Endoplasmic reticulum stress stimulates the expression of cyclooxygenase-2 through activation of NF-kappaB and pp38 mitogen-activated protein kinase. J. Biol. Chem. 279 45 (2004) 46384-46392
11. Mangold C.M., Unckell F., Werr M., and Streeck R.E. Secretion and antigenicity of hepatitis B virus small envelope proteins lacking cysteines in the major antigenic region. Virology 211 2 (1995) 535-543
12. Mangold C.M., Unckell F., Werr M., and Streeck R.E. Analysis of intermolecular disulfide bonds and free sulfhydryl groups in hepatitis B surface antigen particles. Arch. Virol. 142 11 (1997) 2257-2267
13. McCracken A.A., and Brodsky J.L. Assembly of ER-associated protein degradation in vitro: dependence on cytosol, calnexin, and ATP. J. Cell Biol. 132 3 (1996) 291-298
14. McCracken A.A., and Brodsky J.L. A molecular portrait of the response to unfolded proteins. Genome Biol. 1 2 (2000) 101-103 (REVIEWS1013)
15. McCracken A.A., and Brodsky J.L. Evolving questions and paradigm shifts in endoplasmic-reticulum-associated degradation (ERAD). BioEssays 25 9 (2003) 868-877
16. Mehta A.S., Gu B., Conyers B., Ouzounov S., Wang L., Moriarty R.M., Dwek R.A., and Block T.M. Alpha-galactosylceramide and novel synthetic glycolipids directly induce the innate host defense pathway and have direct activity against hepatitis B and C viruses. Antimicrob. Agents Chemother. 48 6 (2004) 2085-2090
17. Meusser B., Hirsch C., Jarosch E., and Sommer T. ERAD: the long road to destruction. Nat. Cell Biol. 7 8 (2005) 766-772
18. Perlmutter D.H. Liver injury in alpha1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury. J. Clin. Invest. 110 11 (2002) 1579-1583
19. Schwarz K., de Giuli R., Schmidtke G., Kostka S., van den Broek M., Kim K.B., Crews C.M., Kraft R., and Groettrup M. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses. J. Immunol. 164 12 (2000) 6147-6157
20. Sheu S.Y., and Lo S.J. Biogenesis of the hepatitis B viral middle (M) surface protein in a human hepatoma cell line: demonstration of an alternative secretion pathway. J. Gen. Virol. 75 Pt 11 (1994) 3031-3039
21. Shih C., and Tai P.C. Detection of hypermodified middle-envelope (M) proteins secreted from naturally occurring HBV variants containing a preS2 internal deletion. Methods Mol. Med. 95 (2004) 165-173
22. Simsek E., Mehta A., Zhou T., Dwek R.A., and Block T. Hepatitis B virus large and middle glycoproteins are degraded by a proteasome pathway in glucosidase-inhibited cells but not in cells with functional glucosidase enzyme. J. Virol. 79 20 (2005) 12914-12920
23. Tai P.C., Suk F.M., Gerlich W.H., Neurath A.R., and Shih C. Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants. Virology 292 1 (2002) 44-58
24. Wang H.C., Chang W.T., Chang W.W., Wu H.C., Huang W., Lei H.Y., Lai M.D., Fausto N., and Su I.J. Hepatitis B virus pre-S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes. Hepatology 41 4 (2005) 761-770
25. Wang H.C., Huang W., Lai M.D., and Su I.J. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci. 97 8 (2006) 683-688
26. Werr M., and Prange R. Role for calnexin and N-linked glycosylation in the assembly and secretion of hepatitis B virus middle envelope protein particles. J. Virol. 72 1 (1998) 778-782
27. Xu Z., Bruss V., and Yen T.S. Formation of intracellular particles by hepatitis B virus large surface protein. J. Virol. 71 7 (1997) 5487-5494
28. Xu Z., Jensen G., and Yen T.S. Activation of hepatitis B virus S promoter by the viral large surface protein via induction of stress in the endoplasmic reticulum. J. Virol. 71 10 (1997) 7387-7392
29. Yewdell J.W., Anton L.C., and Bennink J.R. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?. J. Immunol. 157 5 (1996) 1823-1826